- Home
- Publications
- Publication Search
- Publication Details
Title
PEGylated liposomes: immunological responses
Authors
Keywords
-
Journal
SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
Volume 20, Issue 1, Pages 710-724
Publisher
Informa UK Limited
Online
2019-06-26
DOI
10.1080/14686996.2019.1627174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes
- (2018) Taro Shimizu et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII
- (2018) Lu Lu et al. International Journal of Nanomedicine
- PEGylated TiO2 nanoparticles mediated inhibition of cell migration via integrin beta 1
- (2018) Qingqing Sun et al. SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
- Progress and challenges towards targeted delivery of cancer therapeutics
- (2018) Daniel Rosenblum et al. Nature Communications
- Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes
- (2018) Yuan-Chin Hsieh et al. Theranostics
- Functional biomimetic nanoparticles for drug delivery and theranostic applications in cancer treatment
- (2018) Lei Li et al. SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
- Nanomedicinal products: a survey on specific toxicity and side effects
- (2017) Walter Brand et al. International Journal of Nanomedicine
- Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity
- (2017) Yu Mima et al. JOURNAL OF CONTROLLED RELEASE
- Complement activation turnover on surfaces of nanoparticles
- (2017) S.M. Moghimi et al. Nano Today
- ‘Borono-lectin’ based engineering as a versatile platform for biomedical applications
- (2017) Akira Matsumoto et al. SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
- Factor H Family Proteins in Complement Evasion of Microorganisms
- (2017) Mihály Józsi Frontiers in Immunology
- Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease
- (2016) Hyung-Jun Im et al. ACS Applied Materials & Interfaces
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- Paclitaxel-loaded PEGylated nanocapsules of perfluorooctyl bromide as theranostic agents
- (2016) Tanguy Boissenot et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
- (2016) Peng Zhang et al. JOURNAL OF CONTROLLED RELEASE
- An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome
- (2016) Peter P. Wibroe et al. JOURNAL OF CONTROLLED RELEASE
- Factor H inhibits complement activation induced by liposomal and micellar drugs and the therapeutic antibody rituximab in vitro
- (2016) Tamás Mészáros et al. Nanomedicine-Nanotechnology Biology and Medicine
- Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs
- (2015) Janos Szebeni et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Relationship between the Concentration of Anti-polyethylene Glycol (PEG) Immunoglobulin M (IgM) and the Intensity of the Accelerated Blood Clearance (ABC) Phenomenon against PEGylated Liposomes in Mice
- (2015) Yosuke Hashimoto et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells
- (2015) Taro Shimizu et al. IMMUNOBIOLOGY
- Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed
- (2015) Hidenori Ando et al. JOURNAL OF CONTROLLED RELEASE
- Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy
- (2015) Gianfranco Pasut et al. JOURNAL OF CONTROLLED RELEASE
- Anti-PEG immunity: emergence, characteristics, and unaddressed questions
- (2015) Qi Yang et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Advances and Challenges of Liposome Assisted Drug Delivery
- (2015) Lisa Sercombe et al. Frontiers in Pharmacology
- Liposomal siRNA nanocarriers for cancer therapy
- (2014) Bulent Ozpolat et al. ADVANCED DRUG DELIVERY REVIEWS
- Hypersensitivity Reactions to Intravenous Lipid Emulsion in Swine
- (2014) Peter Bedocs et al. ANESTHESIA AND ANALGESIA
- Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection
- (2014) Huan Xu et al. DRUG DELIVERY
- Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
- (2014) Johan J.F. Verhoef et al. DRUG DISCOVERY TODAY
- Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin
- (2014) Takuya Suzuki et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses
- (2014) László Dézsi et al. JOURNAL OF CONTROLLED RELEASE
- Complement activation-related pseudoallergy: A stress reaction in blood triggered by nanomedicines and biologicals
- (2014) Janos Szebeni MOLECULAR IMMUNOLOGY
- Immediate hypersensitivity reaction following liposomal amphotericin-B (AmBisome) infusion
- (2014) Proggananda Nath et al. TROPICAL DOCTOR
- Biomedical Nanoparticles: Overview of Their Surface Immune-Compatibility
- (2014) Olimpia Gamucci et al. Coatings
- Prolongation of time interval between doses could eliminate accelerated blood clearance phenomenon induced by pegylated liposomal topotecan
- (2013) ChunLei Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration
- (2013) Amr S. Abu Lila et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The influence of lipid composition and surface charge on biodistribution of intact liposomes releasing from hydrogel-embedded vesicles
- (2013) A. Alinaghi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
- (2013) Amr S. Abu Lila et al. JOURNAL OF CONTROLLED RELEASE
- Application of Polyglycerol Coating to Plasmid DNA Lipoplex for the Evasion of the Accelerated Blood Clearance Phenomenon in Nucleic Acid Delivery
- (2013) Amr S. Abu Lila et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The safety and efficacy of peginesatide in patients with CKD
- (2013) Kai-Uwe Eckardt Nature Reviews Nephrology
- Peginesatide for Anemia in Patients with Chronic Kidney Disease Not Receiving Dialysis
- (2013) Iain C. Macdougall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Role of the Methoxy Group in Immune Responses to mPEG-Protein Conjugates
- (2012) Merry R. Sherman et al. BIOCONJUGATE CHEMISTRY
- Peginesatide for Maintenance Treatment of Anemia in Hemodialysis and Nondialysis Patients Previously Treated with Darbepoetin Alfa
- (2012) S. Fishbane et al. Clinical Journal of the American Society of Nephrology
- Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
- (2012) Ricardo P Garay et al. Expert Opinion on Drug Delivery
- Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon
- (2012) Taro Shimizu et al. IMMUNOBIOLOGY
- Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: A possible mechanism and the potential for clinical application
- (2012) Amr S. Abu Lila et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs
- (2012) Takuya Suzuki et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Abrogation of the accelerated blood clearance phenomenon by SOXL regimen: Promise for clinical application
- (2012) Ai Nagao et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: A porcine model
- (2012) János Szebeni et al. JOURNAL OF CONTROLLED RELEASE
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Accelerated Blood Clearance of Pegylated Liposomal Topotecan: Influence of Polyethylene Glycol Grafting Density and Animal Species
- (2012) Chunlei Li et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
- (2011) Janos Szebeni et al. ADVANCED DRUG DELIVERY REVIEWS
- Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients
- (2011) Ninh M. La-Beck et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Repeated injections of PEGylated liposomal topotecan induces accelerated blood clearance phenomenon in rats
- (2011) Yanling Ma et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome
- (2011) János Szebeni et al. Nanomedicine-Nanotechnology Biology and Medicine
- Evasion of the Accelerated Blood Clearance Phenomenon by Coating of Nanoparticles with Various Hydrophilic Polymers
- (2010) Tsutomu Ishihara et al. BIOMACROMOLECULES
- PEGylation of therapeutic proteins
- (2010) Simona JevsÌevar et al. Biotechnology Journal
- Complement: Alive and Kicking Nanomedicines
- (2010) Alina J. Andersen et al. Journal of Biomedical Nanotechnology
- Curvature of Synthetic and Natural Surfaces Is an Important Target Feature in Classical Pathway Complement Activation
- (2010) Martin Bjerregård Pedersen et al. JOURNAL OF IMMUNOLOGY
- Delivery of Therapeutic Proteins
- (2010) Dipak S. Pisal et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase
- (2010) JingXia Cui et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats
- (2010) Masako Ichihara et al. Pharmaceutics
- Minireview: Nanoparticles and the Immune System
- (2009) Banu S. Zolnik et al. ENDOCRINOLOGY
- Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model
- (2009) Amr S. Abu Lila et al. JOURNAL OF CONTROLLED RELEASE
- The role of the anaphylatoxins in health and disease
- (2009) Andreas Klos et al. MOLECULAR IMMUNOLOGY
- Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer
- (2008) Gabriella Ferrandina et al. JOURNAL OF CLINICAL ONCOLOGY
- Liposome-Mediated Triggering of Complement Cascade
- (2008) S. Moein Moghimi et al. JOURNAL OF LIPOSOME RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now